Company Overview

GenScript is a global biotech company offering life sciences products and services across four segments: Life-science services and products, biologics development services, industrial synthetic biology products, and cell therapy.

The company caters to the CRISPR technology market through the Life-science services and products segment. This segment provides reliable, high-quality reagent services, products, and instruments globally, offering custom solutions for gene therapy, cell therapy, antibody therapeutics, vaccines, and diagnostics. The segment covers early discovery to pre-clinical stages with platforms like DNA synthesis, protein expression, and CRISPR tools. It also has expanded into cGMP manufacturing of CRISPR sgRNA, HDR templates, and peptides.

The company operates in over 100 countries and regions, with legal entities established in the U.S., China, Hong Kong, Japan, Singapore, Netherlands, Ireland, the U.K., Korea, and Belgium.

Financial Highlights (FY 2024)